DuPont de Nemours, Inc.

DuPont de Nemours, Inc. is an American advanced specialty solutions company that provides high-performance materials, components, and technologies to healthcare, water, construction, and industrial markets, generating $6.85 billion in revenue on a continuing operations basis in fiscal 2025. Headquartered in Wilmington, Delaware, the company employs approximately 15,000 people and operates manufacturing facilities in roughly 20 countries.

This is a story about a 220-year-old institution that has spent the past decade systematically dismantling and rebuilding itself. After the 2017 Dow-DuPont merger, the subsequent three-way split, and a parade of divestitures culminating in the November 2025 spin-off of Qnity Electronics, what remains is a focused portfolio of roughly equal parts healthcare-and-water technologies and diversified industrials. The post-separation DuPont is smaller, simpler, and more growth-oriented than its conglomerate predecessor — but it is also a company whose post-restructuring identity is still being established in the market's mind. The file turns on a single question: whether the margin and growth trajectory management has laid out can be delivered by a portfolio whose remaining industrial half remains tied to construction and short-cycle manufacturing end markets whose outlook is, at best, mixed.

The Qnity separation and the subsequent sale of the Aramids business to Arclin in April 2026 for approximately $1.1 billion in net proceeds mark the end of the portfolio-reset era and the beginning of what management calls "New DuPont." The first post-separation quarter — Q1 2026 — printed 2% organic growth, 130 basis points of pro forma margin expansion, and double-digit adjusted EPS growth, exceeding guidance. The market has responded with cautious approval: the shares trade near $47, giving the company an enterprise value of roughly $22 billion against management's full-year 2026 operating EBITDA guidance of approximately $1.745 billion — about 12.6 times.